Zepbound, on the other hand, contains the active ingredient tirzepatide
GLP-1 agonists improve glucose tolerance through insulin secretion and weight loss
The concentration of each drug solution was adjusted to maintain the dosing volume at 0.5 mL/kg
The same survey reported that about 60% of GLP-1 users reported drinking less alcohol since beginning treatment, with 14-18% quitting drinking completely
Real-World Use Cases of GLP-1 Analogues Source: Polaris Market Research Analysis Source: Polaris Market Research Analysis GLP-1 Analogues Market Value Chain Analysis The value chain of GLP-1 analogues market begins with the drug development process, which involves drug discovery and preclinical testing
Results During the study period, 31,444 ADR reports were identified: semaglutide (n = 13,956